This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Digestive health disorders impact an estimated 70 million Americans, with irritable bowel syndrome (IBS) ranking as the most common functional gastrointestinal (GI) issue. Prebiotics can positively affect the intestinal flora by stimulating the growth or activity of many types of beneficial gut bacteria. This Whitepaper by Solabia examines the potential of the prebiotic BioEcolians® in improving the well-being of consumers suffering with intestinal disorders.

  • Up to 20 percent of adults in Western countries and Asia experience IBS symptoms.
  • Products formulated with ingredients to support digestive health have been growing in popularity.
  • Studies indicate 81 percent of BioEcolians reaches the gut, where it can be used by the bacteria.